Mediar Therapeutics
Peter Parker is on the Board of Directors at Mediar Therapeutics. Peter is also the Managing General Partner at Mission BioCapital.
This person is not in the org chart
Mediar Therapeutics
Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.